Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 11Recruiting 7Not yet recruiting 4Active not recruiting 4Unknown 3Terminated 2Suspended 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 17Breast 16Genitourinary 12Thoracic 8Other hematologic neoplasm 6Gynecologic 5Tumor-Agnostic 4Lymphoid 4Head & Neck 4CNS 4Sarcoma 2Plasma cell 2Other solid neoplasm 2Other 1Myeloid 1Endocrine 1

Conditions

Neoplasms 2Neoplasm Metastasis 2

Interventions

pembrolizumab 18Specimen Handling 9Magnetic Resonance Spectroscopy 9Bevacizumab 8Biopsy 7Paclitaxel 6Nivolumab 6atezolizumab 5Cyclophosphamide 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Oxaliplatin 4Ipilimumab 4osimertinib 3niraparib 3durvalumab 3cemiplimab 3avelumab 3X-Rays 3Radiotherapy 3Radiosurgery 3Radiation 3Pemetrexed 3Leucovorin 3Irinotecan 3Interviews as Topic 3Fluorouracil 3Carboplatin 3trastuzumab deruxtecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Standard of Care × Tumor-Agnostic × Clear all
NCT06559228 2026-05-08

ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care

University of Minnesota

Phase 2 Active not recruiting
400 enrolled
Tumor-Agnostic

Neoplasms

NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

NRG Oncology

Phase 3 Active not recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03219502 2025-10-14

rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
56 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡